Yaggi, Henry Klar

Obstructive Sleep Apnea as a Risk Factor for Stroke and Death

Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 3,004

Sleep duration as a risk factor for the development of type 2 diabetes

Yaggi, H. K., Araujo, A. B., & McKinlay, J. B. (2006) · Diabetes Care

Sleep and related disordersCircadian rhythm and melatonin

Cited by 790

Obstructive Sleep Apnea as a Risk Factor for Type 2 Diabetes

Botros, N., Concato, J., Mohsenin, V., Selim, B., Doctor, K., & Yaggi, H. K. (2009) · The American Journal of Medicine

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 384

Phenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches

Zinchuk, A. V., Gentry, M. J., Concato, J., & Yaggi, H. K. (2017) · Sleep Medicine Reviews

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 350

Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death

Shah, N. A., Yaggi, H. K., Concato, J., & Mohsenin, V. (2010) · Sleep and Breathing

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 298

The impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME trial

Neeland, I. J., Eliasson, B., Kasai, T., Marx, N., Zinman, B., Inzucchi, S. E., Wanner, C., Zwiener, I., Wojeck, B. S., Yaggi, H. K., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementObstructive Sleep Apnea Research

Cited by 93

Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial

Wojeck, B. S., Inzucchi, S. E., Neeland, I. J., Mancuso, J. P., Frederich, R., Masiukiewicz, U., Cater, N. B., McGuire, D. K., Cannon, C. P., & Yaggi, H. K. (2023) · Sleep and Breathing

Diabetes Treatment and ManagementObstructive Sleep Apnea Research

Cited by 41